Attention Deficit Hyperactivity Disorder Clinical Trial
Official title:
Stimulant Medication Effects on Auditory Sensitivity and Acoustic Reflex in Adolescents With ADHD
NCT number | NCT04577417 |
Other study ID # | 1600804 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | September 13, 2020 |
Est. completion date | June 15, 2022 |
Verified date | December 2022 |
Source | Nemours Children's Clinic |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The aims of this study are to evaluate auditory sensitivity in teenagers with ADHD using acoustic reflex thresholds (ART) and to examine the effects of ADHD stimulant medication on ART.
Status | Completed |
Enrollment | 70 |
Est. completion date | June 15, 2022 |
Est. primary completion date | June 15, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 13 Years to 19 Years |
Eligibility | Inclusion Criteria: Inclusion criteria for all: - Participant must be aged 13 to 19 years - Males and females - All ethnicities - All socioeconomic statuses - Normal hearing - English as a primary language Additional inclusion criteria for ADHD group: - Participants must meet diagnostic criteria for attention-deficit/hyperactivity disorder (ADHD), all subtypes, based on the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) - Stimulant medication with the same drug and dosage for at least 1 year before their enrollment date Exclusion Criteria: - History of any major neurological disorders (e.g. seizures excluding febrile seizure under age 6 years, tumors, brain injury, cerebral palsy, tic disorders) - History of any other major neuropsychiatric disorders (e.g. autism spectrum disorder, mood dysregulation), - Presence of pressure equalization tubes in either ear - Documented hearing impairment 20 decibel or higher hearing loss in either ear - Estimated low cognitive function based on the NIH Toolbox Cognition age-corrected scores (<70) Additional exclusion criteria for the ADHD group - Treatment with any psychotropic medications other than stimulants - Treatment with any ADHD medication other than stimulants (e.g. alpha-agonists, norepinephrine reuptake inhibitors) Additional exclusion criteria for the control group • Treatment with any psychotropic medication |
Country | Name | City | State |
---|---|---|---|
United States | Nemours Children's Health | Wilmington | Delaware |
Lead Sponsor | Collaborator |
---|---|
Nemours Children's Clinic |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Acoustic reflex | Acoustic reflex thresholds in each ear | through study completion, an average of 1 year | |
Primary | Loudness discomfort level | Average loudness levels judged as uncomfortably loud sounds by each participant | through study completion, an average of 1 year | |
Primary | Speech perception in noise | Speech perception scores in each ear measured in two separate sessions | through study completion, an average of 1 year | |
Secondary | Tympanogram | Results of tympanometry (type, volume, pressure, compliance, gradient) to measure middle ear function | through study completion, an average of 1 year | |
Secondary | Otoacoustic emissions | Measure of inner ear function | through study completion, an average of 1 year | |
Secondary | NIH Toolbox Cognition testing | Measures of cognitive functions | through study completion, an average of 1 year | |
Secondary | Hearing screening | Pure-tone hearing test to measure hearing sensitivity | through study completion, an average of 1 year | |
Secondary | Sensory profile questionnaire | Sensory processing assessment | through study completion, an average of 1 year | |
Secondary | Fidgeting | Measure of wrist movements during the testing | through study completion, an average of 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06129396 -
Effects of Aerobic Exercise Intervention in Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)
|
N/A | |
Completed |
NCT04779333 -
Lifestyle Enhancement for ADHD Program 2
|
N/A | |
Recruiting |
NCT05935722 -
Evaluation of a Home-based Parenting Support Program: Parenting Young Children
|
N/A | |
Completed |
NCT03148782 -
Brain Plasticity Underlying Acquisition of New Organizational Skills in Children-R61 Phase
|
N/A | |
Completed |
NCT04832737 -
Strength-based Treatment Approach for Adults With ADHD
|
N/A | |
Recruiting |
NCT04631042 -
Developing Brain, Impulsivity and Compulsivity
|
||
Recruiting |
NCT05048043 -
Development of a Game-supported Intervention
|
N/A | |
Completed |
NCT03337646 -
Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With ADHD and Autism
|
Phase 4 | |
Not yet recruiting |
NCT06454604 -
Virtual Reality Treatment for Emerging Adults With ADHD
|
Phase 2 | |
Not yet recruiting |
NCT06080373 -
Formulation-based CBT for Adult Inmates With ADHD: A Randomized Controlled Trial
|
N/A | |
Not yet recruiting |
NCT06406309 -
Settling Down for Sleep in ADHD: The Impact of Sensory and Arousal Systems on Sleep in ADHD
|
N/A | |
Completed |
NCT02477280 -
Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance
|
Phase 4 | |
Completed |
NCT02911194 -
a2 Milk for Autism and Attention-deficit Hyperactivity Disorder (ADHD)
|
N/A | |
Completed |
NCT02473185 -
Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance During the QbTest
|
Phase 4 | |
Completed |
NCT02390791 -
New Technologies to Help Manage ADHD
|
N/A | |
Completed |
NCT02780102 -
Cognitive-Motor Rehabilitation, Stimulant Drugs, and Active Control in the Treatment of ADHD
|
N/A | |
Completed |
NCT02555150 -
A Comparison of PRC-063 and Lisdexamfetamine in the Driving Performance of Adults With ADHD
|
Phase 3 | |
Completed |
NCT02829970 -
Helping College Students With ADHD Lead Healthier Lifestyles
|
N/A | |
Recruiting |
NCT04175028 -
Neuromodulation of Executive Function in the ADHD Brain
|
N/A | |
Recruiting |
NCT04296604 -
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
|
N/A |